Back
HuagongsheHuagongshe Chemistry Print Report · For research reference only
HRID 1068161Generated: October 31, 2026

Trifluoroacetic acid → alpha-(R)-(3-(S)-((4-(2-Methyl-benzoimidazol-1-yl)piperidin-1-yl)methyl)-4-(S)-phenylpyrrolidin-1-yl)-cyclohexaneacetic acid

https://huagongshe.com/reaction/1068161

Reaction equation

Participants

RoleNameHCIDCharge
ReactantTrifluoroacetic acidHCID 6422—
ReactantAnisoleHCID 7519—
Reactantalpha-(r)-(3-(s)-((4-(2-Methyl-benzoimidazol-1-yl)piperidin-1-yl)methyl)-4-(s)-phenylpyrrolidin-1-yl)-cyclohexaneacetic acid, 4-methoxy-benzyl esterHCID 57317010—
Productalpha-(R)-(3-(S)-((4-(2-Methyl-benzoimidazol-1-yl)piperidin-1-yl)methyl)-4-(S)-phenylpyrrolidin-1-yl)-cyclohexaneacetic acidHCID 20664117103.9%

Reaction Steps

The title compound was prepared from 57 mg of α-(R)-(3-(S)-((4-(2-methyl-benzoimidazol-1-yl)piperidin-1-yl)methyl)-4-(S)-phenyl-pyrrolidin-1-yl)-cyclohexaneacetic acid, 4-methoxy-benzyl ester (from Step C), 4 mL of TFA and 0.3 mL of anisole, using a procedure analogous to that described in Example 95, Step E to provide 48 mg of the title compound as a white solid. ESI-MS 515 (M+H); HPLC A: 1.81 min.

Provenance & Evidence

DOI10.6084/m9.figshare.5104873.v1
Patent numberUS06248755B1
Source datasetuspto-grants-2001_06
ORD IDord-1efcc57aa9bf43a7bb27222eff73b98e
Source noteuspto-grants-2001_06